Search Results - "Alteri, E"

Refine Results
  1. 1
  2. 2

    An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug by Bakshi, R., Hermeling-Fritz, I., Gathmann, I., Alteri, E.

    “…Artemether-lumefantrine (A-L), a new fixed-dose oral antimalarial drug, combines the fast onset of action of artemether (an artemisinin derivative) in terms of…”
    Get full text
    Journal Article
  3. 3

    A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity by Meyer, T, Regenass, U, Fabbro, D, Alteri, E, Rösel, J, Müller, M, Caravatti, G, Matter, A

    Published in International journal of cancer (15-05-1989)
    “…Analogues of staurosporine were synthesized and their ability to inhibit protein kinases was examined. Staurosporine is a potent but non-selective inhibitor of…”
    Get more information
    Journal Article
  4. 4

    CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity by ALTERI, E, BOLD, G, WALKER, M, WOODS-COOK, K, COZENS, R, FAESSLER, A, KLIMKAIT, T, LANG, M, LAZDINS, J, PONCIONI, B, ROESEL, J. L, SCHNEIDER, P

    Published in Antimicrobial Agents and Chemotherapy (01-10-1993)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Anti-HIV-1 Activity in Vitro of Ceftazidime Degradation Products by Hobi, Reinhard, Hübscher, Ulrich, Neftel, Klaus, Alteri, Enrica, Poncioni, Bernard, Walker, Maja R, Woods-Cook, Kathie, Schneider, Peter, Lazdins, Janis K

    Published in Antiviral chemistry & chemotherapy (01-03-2001)
    “…Cephalosporins in aqueous solutions generate degradation products that inhibit in vitro HIV-1 replication in cell lines, as well as in primary cells…”
    Get full text
    Journal Article
  7. 7

    Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance by Francis, Gordon S, Grumser, Yves, Alteri, Enrica, Micaleff, Alain, O'Brien, Fanny, Alsop, Jonathan, Stam Moraga, Margaretha, Kaplowitz, Neil

    Published in Drug safety (2003)
    “…Hepatic dysfunction, manifested as liver enzyme elevations, occurs frequently in patients who are treated with interferon, however, data for patients with…”
    Get full text
    Journal Article
  8. 8

    Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis by Rieckmann, Peter, O'Connor, Paul, Francis, Gordon S, Wetherill, Graham, Alteri, Enrica

    Published in Drug safety (2004)
    “…Interferon-beta-1a (Rebif) is an established treatment for relapsing-remitting multiple sclerosis (MS) and haematological changes are commonly reported in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    N-formylmethionyl-leucyl-[3H]phenylalanine binding, superoxide release, and chemotactic responses of human blood monocytes that repopulate the circulation during leukapheresis by Alteri, E, Leonard, EJ

    Published in Blood (01-10-1983)
    “…Human blood monocytes comprise two subpopulations: one migrates to the chemoattractant, N-formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe), and has…”
    Get full text
    Journal Article
  11. 11

    In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attack by Martelletti, P, Alteri, E, Pesce, A, Rinaldi-Garaci, C, Giacovazzo, M

    Published in Journal of neuroimmunology (01-04-1988)
    “…Serotonin (5-HT) binds in a saturable and specific manner to high affinity binding sites present on the surface of human mononuclear cells. The serotonin…”
    Get more information
    Journal Article
  12. 12
  13. 13

    An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugs by Rordorf-Adam, C, Lazdins, J, Woods-Cook, K, Alteri, E, Henn, R, Geiger, T, Feige, U, Towbin, H, Erard, F

    “…The monokines interleukin-1 beta and alpha (IL-1) play a central role in the connective tissue destruction of many chronic inflammatory diseases. A high…”
    Get more information
    Journal Article
  14. 14
  15. 15

    TGF-beta: upregulator of HIV replication in macrophages by Lazdins, J K, Klimkait, T, Alteri, E, Walker, M, Woods-Cook, K, Cox, D, Bilbe, G, Shipman, R, Cerletti, N, McMaster, G

    Published in Research in virology (Paris) (1991)
    “…TGF-beta at physiological concentrations, when added to monocyte-derived macrophages following HIV1 infection, has an enhancing effect upon the rate of virus…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes by Lazdins, JK, Klimkait, T, Woods-Cook, K, Walker, M, Alteri, E, Cox, D, Cerletti, N, Shipman, R, Bilbe, G, McMaster, G

    Published in The Journal of immunology (1950) (15-08-1991)
    “…In vitro-differentiated monocytes can be infected with the monocytotropic isolate of HIV-1/ADA. The infection is characterized by formation of giant cells and…”
    Get full text
    Journal Article
  20. 20

    The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages by Lazdins, J K, Woods-Cook, K, Walker, M, Alteri, E

    Published in AIDS research and human retroviruses (01-10-1990)
    “…Cultured monocyte-derived macrophages were productively infected with human immunodeficiency virus in vitro. Treatment of these cells shortly after infection…”
    Get more information
    Journal Article